Patents by Inventor Jurgen Braunger

Jurgen Braunger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indolopyridines as Eg5 kinesin modulators
    Patent number: 8530493
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: September 10, 2013
    Assignee: 4SC AG
    Inventors: Matthias Vennemann, Thomas Bãr, Jürgen Braunger, Astrid Zimmermann, Volker Gekeler
  • Benzothienopyridines for use as inhibitors of Eg5 kinesin
    Patent number: 7718665
    Abstract: Compounds of the formula (1) in which R1, R2, R3, R4 and X have the meanings indicated in the description, are novel effective compounds with Eg5 inhibitory, anti-proliferative and/or apoptosis inducing activity.
    Type: Grant
    Filed: August 17, 2005
    Date of Patent: May 18, 2010
    Assignee: 4SC AG
    Inventors: Matthias Vennemann, Thomas Baer, Gudrun Groegor, Jürgen Braunger, Petra Gimmnich, Thomas Maier, Heike Rothfels
  • BENZOPYRANOPYRAZOLES
    Publication number: 20100104659
    Abstract: Compounds of a certain formula I, in which Ra, Rb and Rc have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: July 12, 2007
    Publication date: April 29, 2010
    Inventors: Matthias Vennemann, Thomas Bär, Thomas Maier, Andreas Lindenmaier, Jürgen Braunger, Markus Boehm, Astrid Zimmermann, Volker Gekeler
  • INDOLOPYRIDINES AS EG5 KINESIN MODULATORS
    Publication number: 20090246169
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: February 21, 2007
    Publication date: October 1, 2009
    Inventors: Matthias Vennemann, Thomas Bar, Jürgen Braunger, Astrid Zimmermann, Volker Gekeler
  • INDOLOPYRIDINES AS EG5 KINESIN MODULATORS
    Publication number: 20090233902
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: February 21, 2007
    Publication date: September 17, 2009
    Inventors: Matthias Vennemann, Thomas Bãr, Jürgen Braunger, Astrid Zimmermann, Volker Gekeler
  • Novel Pyrrolodihydroisoquinolines as Pde 10 Inhibitors
    Publication number: 20080161338
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of PDE10.
    Type: Application
    Filed: January 11, 2006
    Publication date: July 3, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Paola Ciapetti, Jean-Marie Contreras, Camille George Wermuth
  • Indolopyridines,Benzofuranopyridines and Benzothienopyridines
    Publication number: 20080125452
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5 and X have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 29, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Petra Gimmnich, Thomas Beckers, Mathias Schmidt, Thomas Ciossek, Sandra Nappe
  • Novel Indolopyridines, Benzofuranopyridines and Benzothienopyridines
    Publication number: 20080114017
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and X have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 15, 2008
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Petra Gimmnich
  • Benzothienopyridines for Use as Inhibitors of Eg5 Kinesin
    Publication number: 20070232596
    Abstract: Compounds of the formula (1) in which R1, R2, R3, R4 and X have the meanings indicated in the description, are novel effective compounds with Eg5 inhibitory, anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: August 17, 2005
    Publication date: October 4, 2007
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Baer, Gudrun Groegor, Jurgen Braunger, Petra Gimmnich, Thomas Maier, Heike Rothfels
  • Novel pyrrolodihydroisoquinolines useful in the treatment of cancer
    Publication number: 20060148838
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of cellular (hyper)proliferation and/or inducers of apoptosis in cancer cells.
    Type: Application
    Filed: June 30, 2004
    Publication date: July 6, 2006
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Volker Gekeler
  • Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
    Publication number: 20060148804
    Abstract: The invention relates to the use of certain PDE4 inhibitors alone or in combination with one or more differentiation inducing agents and/or an agent effective in raising intracellular concentrations of cAMP or a stable analogue of cAMP in the preparation of pharmaceutical compositions for the treatment of neoplasms of lymphoid cells.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 6, 2006
    Inventors: Jurgen Braunger, Christian Schudt
  • Pyrrolodihydroisoquinolines as pde10 inhibitors
    Publication number: 20060148840
    Abstract: The invention relates to novel pyrrolodihydroisoquinoline derivatives, which are efficacious inhibitors of PDE10.
    Type: Application
    Filed: June 30, 2004
    Publication date: July 6, 2006
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger